Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryotherapy | 2 | 2018 | 36 | 1.160 |
Why?
|
| Pain | 2 | 2018 | 472 | 0.910 |
Why?
|
| Chronic Disease | 4 | 2018 | 1329 | 0.630 |
Why?
|
| Venlafaxine Hydrochloride | 4 | 2019 | 42 | 0.620 |
Why?
|
| Venous Insufficiency | 1 | 2018 | 27 | 0.620 |
Why?
|
| Self Efficacy | 1 | 2018 | 199 | 0.580 |
Why?
|
| Leg | 1 | 2018 | 191 | 0.570 |
Why?
|
| Self-Management | 1 | 2018 | 82 | 0.570 |
Why?
|
| Compression Bandages | 1 | 2016 | 6 | 0.560 |
Why?
|
| Blood Circulation | 1 | 2016 | 18 | 0.560 |
Why?
|
| Pain Management | 1 | 2018 | 186 | 0.540 |
Why?
|
| Electroconvulsive Therapy | 5 | 2019 | 402 | 0.540 |
Why?
|
| Varicose Ulcer | 1 | 2016 | 42 | 0.530 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 1851 | 0.510 |
Why?
|
| Wound Healing | 1 | 2016 | 260 | 0.480 |
Why?
|
| Telemedicine | 1 | 2022 | 699 | 0.450 |
Why?
|
| Skin | 1 | 2016 | 451 | 0.440 |
Why?
|
| Uncertainty | 1 | 2010 | 31 | 0.370 |
Why?
|
| Probability | 1 | 2010 | 244 | 0.360 |
Why?
|
| Depressive Disorder, Major | 3 | 2019 | 438 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 938 | 0.330 |
Why?
|
| Models, Statistical | 1 | 2010 | 448 | 0.290 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 848 | 0.280 |
Why?
|
| Aged | 11 | 2019 | 14842 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 4843 | 0.200 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 91 | 0.200 |
Why?
|
| Middle Aged | 10 | 2018 | 21119 | 0.190 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 99 | 0.190 |
Why?
|
| Female | 14 | 2021 | 38021 | 0.180 |
Why?
|
| Male | 13 | 2021 | 37283 | 0.180 |
Why?
|
| Humans | 16 | 2022 | 68549 | 0.180 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 23 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2022 | 339 | 0.170 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 216 | 0.170 |
Why?
|
| Quality of Life | 2 | 2017 | 1515 | 0.160 |
Why?
|
| Postthrombotic Syndrome | 1 | 2018 | 6 | 0.160 |
Why?
|
| Tobacco Use Cessation | 1 | 2018 | 44 | 0.160 |
Why?
|
| Smoking Cessation | 2 | 2018 | 1032 | 0.160 |
Why?
|
| Pandemics | 1 | 2022 | 349 | 0.160 |
Why?
|
| Lithium Compounds | 1 | 2017 | 15 | 0.150 |
Why?
|
| Hospital Administration | 1 | 2018 | 43 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 364 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2018 | 93 | 0.150 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 146 | 0.140 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 91 | 0.140 |
Why?
|
| Tobacco Use Disorder | 2 | 2018 | 432 | 0.140 |
Why?
|
| Lithium | 1 | 2016 | 76 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 201 | 0.130 |
Why?
|
| Mass Screening | 1 | 2021 | 838 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 346 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2018 | 267 | 0.130 |
Why?
|
| Combined Modality Therapy | 4 | 2019 | 951 | 0.130 |
Why?
|
| Adult | 7 | 2018 | 21379 | 0.130 |
Why?
|
| Social Determinants of Health | 1 | 2016 | 96 | 0.130 |
Why?
|
| Poverty | 1 | 2016 | 218 | 0.130 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 133 | 0.120 |
Why?
|
| Child | 2 | 2022 | 6401 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2016 | 621 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1265 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2798 | 0.100 |
Why?
|
| Binomial Distribution | 1 | 2010 | 4 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2011 | 103 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 79 | 0.090 |
Why?
|
| Albuminuria | 1 | 2011 | 171 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 306 | 0.090 |
Why?
|
| South Carolina | 4 | 2018 | 2752 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2011 | 195 | 0.090 |
Why?
|
| Depression | 1 | 2016 | 942 | 0.080 |
Why?
|
| Stroke | 1 | 2021 | 2162 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2011 | 307 | 0.080 |
Why?
|
| Georgia | 2 | 2018 | 161 | 0.070 |
Why?
|
| Kidney | 1 | 2011 | 945 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 729 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 517 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2019 | 7028 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 1449 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 782 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2018 | 374 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 839 | 0.060 |
Why?
|
| Hypertension | 1 | 2011 | 1533 | 0.050 |
Why?
|
| Placebos | 1 | 2018 | 195 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 255 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 257 | 0.040 |
Why?
|
| Inpatients | 1 | 2018 | 208 | 0.040 |
Why?
|
| Remission Induction | 1 | 2016 | 111 | 0.040 |
Why?
|
| Self Administration | 1 | 2018 | 419 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 503 | 0.030 |
Why?
|
| Community Health Workers | 1 | 2016 | 32 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2017 | 291 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 648 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 880 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3256 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1054 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3187 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 429 | 0.030 |
Why?
|
| Cognition | 1 | 2016 | 512 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2356 | 0.030 |
Why?
|
| Health Promotion | 1 | 2016 | 407 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1738 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 3703 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 274 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 546 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 7268 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 737 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8904 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1609 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1860 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2004 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2265 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 4655 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5720 | 0.010 |
Why?
|